GLOW Blend Peptide – User Manual & Dosage Protocol Guide

1

Product Overview

GLOW Blend Peptide is a proprietary peptide formulation designed to support skin rejuvenation, anti-aging, and overall cellular vitality. It is commonly used in experimental settings for:

  • Improving skin elasticity and firmness
  • Promoting collagen synthesis
  • Reducing the appearance of fine lines and wrinkles
  • Supporting cellular repair and regeneration

Disclaimer: GLOW Blend Peptide is for research and experimental use only. It is not FDA-approved for cosmetic or medical purposes. Always consult a qualified healthcare professional before use.

2

Forms Available

Lyophilized Powder

  • Description: Freeze-dried peptide blend for reconstitution

Injection Solution

  • Description: Reconstituted solution for subcutaneous (SC) or intramuscular (IM) injection
3

Mechanism of Action

The GLOW Blend Peptide contains a combination of peptides that may work synergistically to:

  • Stimulate collagen and elastin production in skin tissue
  • Promote cellular repair and regeneration
  • Improve skin hydration and tone
  • Provide antioxidant and anti-aging support

Effects are primarily observed in experimental research settings and limited human trials.

4

Dosage Protocol (Investigational)

Administration

Subcutaneous (SC) Injection

  • Typical Dose: 2–5 mg
  • Frequency: 2–3× per week
  • Notes: Administer near areas of skin concern for targeted effects

Intramuscular (IM) Injection

  • Typical Dose: 2–5 mg
  • Frequency: 1–2× per week
  • Notes: Can be administered systemically or locally

Oral/Topical (if included in blend)

  • Typical Dose: As per product instructions
  • Frequency: Daily
  • Notes: Bioavailability may vary; effects are generally slower than injections
Cycle Protocol (Investigational)

Initial Phase

  • Duration: 2–4 weeks
  • Dose: 2 mg SC/IM, 2× per week
  • Notes: Assess tolerance and response

Therapeutic Phase

  • Duration: 4–8 weeks
  • Dose: 3–5 mg SC/IM, 2–3× per week
  • Notes: Full effect on skin and cellular repair

Rest Period

  • Duration: 1–2 months
  • Dose: None
  • Notes: Allow the body to reset before the next cycle
5

Reconstitution Instructions (Lyophilized Powder)

Supplies Needed:

  • Sterile bacteriostatic water
  • Sterile syringe
  • Alcohol swabs

Steps:

  1. Clean vial with alcohol swab.
  2. Add the desired volume of bacteriostatic water (e.g., 10 mg peptide + 2 mL water → 5 mg/mL solution).
  3. Swirl gently to dissolve; do not shake.
  4. Store reconstituted solution refrigerated (2–8°C).
  5. Use within 2–4 weeks; discard if cloudy or discolored.
6

Administration Guidelines

Subcutaneous Injection (SC)
  1. Select a clean injection site near areas of concern (e.g., face, neck, arms).
  2. Clean the site with alcohol swab.
  3. Insert needle at 45° angle.
  4. Inject slowly and steadily.
  5. Apply gentle pressure; rotate injection sites to avoid irritation.
Intramuscular Injection (IM)
  1. Select a clean muscle site (deltoid, glute, thigh).
  2. Clean with alcohol swab.
  3. Insert needle at 90° angle and inject slowly.
  4. Apply gentle pressure afterward.

Tip: SC injections near skin-targeted areas may provide more visible skin benefits.

7

Storage Guidelines

Storage Information

Lyophilized Powder

  • Storage: Cool, dry place
  • Shelf Life: Up to 12 months

Reconstituted Solution

  • Storage: Refrigerate at 2–8°C
  • Shelf Life: 2–4 weeks

Important:
Discard the solution if it becomes cloudy, discolored, or contains particulates.

8

Safety & Precautions

  • Not for pregnant or breastfeeding women
  • Avoid if allergic to peptides
  • Possible mild side effects: irritation at injection site, redness, swelling
  • Discontinue if severe reactions occur
  • Keep out of reach of children

Effects in humans are primarily investigational.

9

Quick Reference Cycle Chart (Investigational)

Weekly Cycle Schedule

Week 1–2

  • Dose: 2 mg SC/IM, 2× per week
  • Notes: Initial tolerance phase

Week 3–4

  • Dose: 3 mg SC/IM, 2–3× per week
  • Notes: Therapeutic dose escalation

Week 5–8

  • Dose: 5 mg SC/IM, 2–3× per week
  • Notes: Full effect cycle

Week 9+

  • Dose: Rest
  • Notes: 1–2 month break before the next cycle
10

Visual Guide

  • Diagrams of SC injection sites near facial, neck, or limb areas
  • Step-by-step reconstitution guide
  • Safety icons for handling, storage, and injections